COVID-19: Vaccines and Therapeutics
Minority Health Month Exclusive: Covid-Vaccine Muslim Community Partnerships. A conversation between AHA, the Islamic Center of America and Henry Ford Health System.
The monoclonal antibody therapy REGEN-COV (casirivimab with imdevimab) reduced the risk of symptomatic COVID-19 in household contacts of people with SARS-CoV-2 by 81% in a phase 3 clinical trial conducted with the National Institute of Allergy and Infectious Diseases, Regeneron Pharmaceuticals…
The Food and Drug Administration and Centers for Disease Control and Prevention jointly recommended a pause in the use of Johnson & Johnson’s COVID-19 vaccine, following six reported cases of rare but severe types of blood clots following the vaccine’s administration.
Photo Credit: Penn Medicine
As Rush University Medical Center in Chicago ramped up COVID-19 vaccine distribution across the communities it serves, infectious disease experts looked for effective ways to connect with a key group: people who have reservations about taking the vaccine.
Pfizer said it is seeking an amended emergency use authorization for its COVID-19 vaccine, requesting that the Food and Drug Administration allow its use for individuals between 12 and 15 years old.
While many churches across the U.S. have been waiting to open their doors to their entire congregation for worship during the pandemic, they are taking on a new role: vaccination clinics. In Jackson, Mississippi, St. Dominic Hospital is working with local churches to make sure more people have…
The Centers for Medicare & Medicaid Services (CMS) April 7 issued its fiscal year (FY) 2022 proposed rule for the inpatient psychiatric facility (IPF) prospective payment system (PPS). CMS will accept comments on this rule through June 7.
Here are the stories of how hospitals and health systems are vaccinating a nation through creativity, collaboration and compassion.
Nearly 80% of prekindergarten through 12th grade teachers, school staff and child care workers had received at least their first COVID-19 shot by April, the Centers for Disease Control and Prevention announced yesterday.